Ticker Details
Atyr Pharma, Inc.
IPO Date:	May 12, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$73.54M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 3.66%
Avg Daily Range (30 D):	$0.03 | 3.05%
Avg Daily Range (90 D):	$0.03 | 3.49%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	.86M
Avg Daily Volume (90 D):	1.44M

Trade Size
Avg Trade Size (Sh.):	260
Avg Trade Size (Sh.) (30 D):	214
Avg Trade Size (Sh.) (90 D):	277

Institutional Trades
Total Institutional Trades:	124
Avg Institutional Trade:	$1.71M
Avg Institutional Trade (30 D):	$2.74M
Avg Institutional Trade (90 D):	$1.67M
Avg Institutional Trade Volume:	.52M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.68M
Avg Closing Trade (30 D):	$2.74M
Avg Closing Trade (90 D):	$2.74M
Avg Closing Volume:	507.37K

News

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Dec 6, 2025 @ 5:58 PM ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Inve... Source: Reed Kathrein

Dec 6, 2025 @ 1:53 PM ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & S... Source: Bragar Eagel & Squire, P.C.

Dec 6, 2025 @ 2:38 AM מועד אחרון לת... Source: Rosen Law Firm

Dec 5, 2025 @ 10:57 PM ATYR DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED ... Source: Rosen Law Firm

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.8	$-.14	$-.8
Diluted EPS	$-.8	$-.14	$-.8
Revenue	$.19M	$M	$.19M
Gross Profit
Net Income / Loss	$-74.12M	$-13.96M	$-74.12M
Operating Income / Loss	$-77.63M	$-14.8M	$-77.63M
Cost of Revenue
Net Cash Flow	$-1.03M	$4.12M	$-1.03M
PE Ratio